BioCentury
ARTICLE | Company News

Sanofi, AstraZeneca deal

September 14, 2015 7:00 AM UTC

Sanofi’s Genzyme Corp. unit will purchase Caprelsa vandetanib from AstraZeneca for $165 million up front and up to $135 million in development and sales milestones. The EGFR and VEGF receptor kinas...